215317-08-1 Usage
Uses
Used in Organic Synthesis:
(R)-(4-phenylphenoxy)methyl-3-(2-phenylethyl)-3-[(4-phenylphenoxy)methoxy]hexanoate is used as an intermediate in organic synthesis for the creation of various complex organic compounds. Its unique structure, including phenyl groups and an ester functional group, allows for versatile reactions and the formation of a wide range of products.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, (R)-(4-phenylphenoxy)methyl-3-(2-phenylethyl)-3-[(4-phenylphenoxy)methoxy]hexanoate is used as a potential building block for the development of new drugs. Its hydrophobic nature and structural complexity make it a candidate for the design of molecules with specific biological activities, targeting various therapeutic areas.
Used in Chemical Research:
(R)-(4-phenylphenoxy)methyl-3-(2-phenylethyl)-3-[(4-phenylphenoxy)methoxy]hexanoate is also utilized in chemical research to study the properties and reactivity of complex organic molecules. Understanding its behavior in different reaction conditions can provide insights into the development of new synthetic methods and the creation of novel compounds with specific applications.
Used in Material Science:
Within the field of material science, (R)-(4-phenylphenoxy)methyl-3-(2-phenylethyl)-3-[(4-phenylphenoxy)methoxy]hexanoate may be employed in the development of new materials with tailored properties. Its aromatic and hydrophobic characteristics could contribute to the creation of materials with improved performance in areas such as coatings, adhesives, or polymers.
Check Digit Verification of cas no
The CAS Registry Mumber 215317-08-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,5,3,1 and 7 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 215317-08:
(8*2)+(7*1)+(6*5)+(5*3)+(4*1)+(3*7)+(2*0)+(1*8)=101
101 % 10 = 1
So 215317-08-1 is a valid CAS Registry Number.
215317-08-1Relevant articles and documents
Process to produce a protease inhibitor
-
, (2008/06/13)
Disclosed is a novel process and novel intermediates to prepare [R-(R*,R*)]-N-[3-[1-[5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)-2-pyridinesulfonamide (XIX) which is a protease inhibitor useful in treating humans infected with the HIV virus.
A convergent, scalable synthesis of HIV protease inhibitor PNU-140690
Fors, Kristina S.,Gage, James R.,Heier, Richard F.,Kelly, Robert G.,Perrault, William R.,Wicnienski, Nancy
, p. 7348 - 7356 (2007/10/03)
PNU-140690, an inhibitor of the HIV protease enzyme undergoing clinical evaluation as a chemotherapeutic agent for treatment of AIDS, was synthesized by a convergent approach amenable to large-scale preparation in a pilot plant environment. The key step is the aldol addition of nitroaromatic ester (+)-8 to aldehyde 19e. The two stereocenters present in the target molecule were each set independently by resolution of enantiomers. Intermediates along the synthetic routes were chosen to maximize opportunities for isolation and purification by crystallization.
